ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

February 23, 2015 Group News
shutterstock_75799198

ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

CryoSave, part of ESPERITE, is the only private cord blood bank sponsoring a GCP clinical trial according to GMP-ATMP international guidelines

CryoSave leads and sponsors a multicentre clinical trial following GCP-ICH standards, for investigation of new treatment of Cerebral Palsy using dual infusion of two types of stem cells derived from umbilical cord blood and cord tissue processed by CryoSave

Geneva, Switzerland – 23 February 2015

read more

ESPERITE’S R&D division “The Cell Factory” implements GMP stem cell bioproduction technology and aims the cerebral palsy as first clinical trial

September 25, 2014 Group News
blog_img2

Esperite (Euronext.: ESP), the European leader in stem cells cryopreservation now entering the fields of predictive medicine and translational regenerative medicine R&D, implements its own proprietary new technology for clinical grade production of autologous mesenchymal and stromal stem cells in its business unit The Cell Factory.

Zutphen, The Netherlands – 25 September 2014

read more

Child with cerebral palsy treated with umbilical cord blood derived autologous stem cells

December 12, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe announces that on December 10th 2013 a 4-year-old girl in Spain received an infusion of stem cells derived from her own umbilical cord blood for the treatment of her cerebral palsy. Cerebral palsy is one of the main areas of investigation of umbilical cord blood stem cell therapies.

read more

Girl with cerebral palsy treated with own cord blood stem cells

July 28, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, “Cryo-Save”), Europe’s leading family stem cell bank, released a cord blood sample of a six-year-old girl from Portugal. The girl will be treated with her own umbilical cord blood stem cells at Duke University (USA) for cerebral palsy (CP). Cerebral palsy refers to a number of neurological disorders that appear in infancy or early childhood and permanently affects body movement and muscle coordination. It is a serious brain injury for which there is no standard cure available. The little girl received the first reinfusion of her own stem cells earlier this week.

read more

Cerebral palsy boy treated with own cord blood stem cells

December 14, 2010 Group News

Cryo-Save Group N.V. (Euronext: CRYO, “Cryo-Save”), Europe’s leading stem cell bank, today announces that another sample has been released. A six year old boy from Portugal went to Duke University (USA) to participate in a FDA approved clinical trial for cerebral palsy (CP). Cerebral palsy is a form of brain injury which causes physical disability and has no standard cure at the moment.

read more